- Long-Term Effects of COVID-19
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Gastrointestinal Tumor Research and Treatment
- Healthcare Systems and Technology
- COVID-19 and healthcare impacts
- Autoimmune Bullous Skin Diseases
- Health Systems, Economic Evaluations, Quality of Life
- Comparative International Legal Studies
- Archaeological and Historical Studies
- Cardiac pacing and defibrillation studies
- Lymphadenopathy Diagnosis and Analysis
- Systemic Lupus Erythematosus Research
- Galician and Iberian cultural studies
- Immunodeficiency and Autoimmune Disorders
- Biomedical Research and Pathophysiology
- Inflammasome and immune disorders
- Cancer Immunotherapy and Biomarkers
- Medical research and treatments
- Drug-Induced Adverse Reactions
- Eosinophilic Esophagitis
- Employment, Labor, and Gender Studies
- Cardiac Imaging and Diagnostics
- HIV/AIDS oral health manifestations
- Skin Diseases and Diabetes
Hospital General Universitario Gregorio Marañón
2018-2025
University of Pisa
2018
BioCruces Health research Institute
2018
University of the Basque Country
2018
Hôpital Cochin
2018
Assistance Publique – Hôpitaux de Paris
2018
Abstract Some patients with COVID-19 pneumonia develop an associated cytokine storm syndrome that aggravates the pulmonary disease. These may benefit of anti-inflammatory treatment. The role colchicine in hospitalized and established hyperinflammation remains unexplored. In a prospective, randomized controlled, observer-blinded endpoint, investigator-initiated trial, 240 were randomly allocated to receive oral or not. primary efficacy outcome measure was composite non-invasive mechanical...
To analyse the real-life practice on use of Tacrolimus (TAC) in patients with systemic lupus erythematosus (SLE) from three European SLE referral centres.Adult regularly followed at centres were included. Demographics, cumulative organ involvement, treatment history, Systemic Lupus Disease Activity Index (SLEDAI), laboratory features and physician's judgement collected baseline 3-6-12 months after starting TAC.29 included (89% female, mean age 38±9 years). Ethnicity was predominantly...
Acetylsalicylic acid (ASA) is widely used in the treatment and prevention of cardiovascular disorders. Our objective to evaluate its possible protective role, not only mortality but also other aspects such as inflammation, symptomatic thrombosis, intensive care unit (ICU) admission hospitalized COVID-19 patients. We realized an observational retrospective cohort study 20,641 patients with pneumonia collected followed-up from Mar 1st, 2020 May 2021, nationwide Spanish SEMI-COVID-19 Registry....
Abstract In 2020, the COVID-19 pandemic followed a two-wave pattern in most countries. Hospital admission for one wave or another could have affected mortality, especially among older persons. The objective of this study was to evaluate whether patients during different waves, before SARS-CoV-2 vaccination available, associated with mortality. We compared mortality rates hospitalized 2020 (first wave) and after (second July 7, included SEMI-COVID-19 Registry, large, multicenter,...
To describe the impact of different doses corticosteroids on evolution patients with COVID-19 pneumonia, based potential benefit non-genomic mechanism these drugs at higher doses.Observational study using data collected from SEMI-COVID-19 Registry. We evaluated epidemiological, radiological and analytical scenario between treated megadoses therapy vs low-dose development complications. The primary endpoint was all-cause in-hospital mortality according to use megadoses.Of a total 14,921...
Introducción: Desde que se inició la pandemia por el SARS-CoV-2, han descrito numerosos casos de síndrome Guillain-Barré secundario a COVID-19. Su presentación típica es triada parestesias, debilidad muscular ascendente y arreflexia, aunque hay diversas variantes regionales como diplejía facial.
 Presentación del caso: Mujer 35 años que, dos semanas después un contacto estrecho con caso confirmado COVID-19, ingresa miopericarditis probablemente viral, estudio autoinmunidad negativo,...